GlaxoSmithKline (GB:GSK) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
GSK plc has announced the acquisition of American Depositary Shares (ADSs) by Dr Hal Barron, a Non-Executive Director, and James Ford, SVP and Group General Counsel, as part of their respective savings plans through dividend reinvestment. The transactions took place on November 15, 2024, at the New York Stock Exchange, with ADSs priced at $33.35. This move reflects GSK’s ongoing commitment to aligning executive interests with shareholder value.
For further insights into GB:GSK stock, check out TipRanks’ Stock Analysis page.
